February 10, 2014

MYTRUS AND PFIZER WIN BEST PRACTICES AWARD FOR PIONEERING WORK IN ELECTRONIC CONSENT AND VIRTUAL TRIALS.

Prestigious award granted to innovative partnership at the Strategic Innovation in Clinical Trials Summit for Clinical Operations Executives (SCOPE).

Davis, CA (February 10, 2014) - Today Mytrus, Inc. announced that they have been recognized with a Best Practices Award from Clinical Informatics News for a project conducted for Pfizer, Inc. The award was presented during the 2014 Summit for Clinical Ops Executives (SCOPE) held last week in Miami. Established last year, the Clinical Informatics News Best Practices Awards recognizes clinical organizations for outstanding strategic innovation - partnerships, deployments, or collaborations that manifestly improve the clinical trial process. Nominees were judged by a panel that included two editors and five industry experts.

In the category of "Patient Data Management," Mytrus and Pfizer received a joint award for their implementation of the first clinical trials direct-to-patient data system. This technology empowered patients on a Pfizer Overactive Bladder (OAB) trial to participate from home in every aspect of the study from recruitment and informed consent to regular reporting of clinical and drug safety data. The system also enabled the delivery of study data direct to participants upon the trial’s conclusion.

"We are honored to have worked closely with Pfizer in this important clinical trial which we believe will pave the way for many other new innovations in clinical research methods" said Anthony Costello, CEO of Mytrus. "We are convinced that simplifying clinical trials for patients is a key to dramatically changing the time and cost of bringing new drugs to market."

Awards finalists and winners were selected for their innovative use of clinical technologies including informatics, information technology, and knowledge management on a project or organizational level to achieve significantly improved results in clinical operations, clinical trial planning, or patient service. Other winners included Clinical Ink and Forte Research Systems.

Judges rated entries on innovation, importance, return on investment and likely industry impact, seeking stories that spotlighted the practical and positive deployment of novel technologies in academic, medical or commercial organizations. Judges included Clinical Informatics News editor Allison Proffitt; staff reporter Aaron Krol; Stephen Fogelson with Develotron; Naila Ganatra, Barnett International; Beth Harper of Clinical Performance Partners, Inc.; Joseph Kim with Shire Pharmaceuticals; and, Phillips Kuhl, Cambridge Healthtech Institute. Competitors included pharmaceutical companies, medical centers and clinical tools providers from around the world.

This is the second prestigious award in six months for Mytrus, which last August received Frost & Sullivan’s North American Product Leadership Award in Clinical Trials for their pioneering electronic informed consent application, enroll™. Frost & Sullivan, a respected global research organization that tracks more than 250,000 companies, compared Mytrus to other market competitors in a rigorous review that touched on several elements of product design, adoption, ease of use and market potential. At the end of the review, Frost & Sullivan said Mytrus had developed a disruptive innovation that made the cumbersome, but critical process of informed consent simple and efficient for patients while offering trial sponsors and regulators new opportunities to collect and track important informed consent data analytics.

About Mytrus

Founded in 2009, Mytrus is a privately held e-clinical technology company specializing in patient-centered electronic informed consent and data collection tools. After receiving the first FDA approvals for remote electronic consent and virtual data collection, Mytrus has gone on to develop new technologies for patients including ePRO and EDC tools usable from home and mobile devices, bio-sample consent tracking technology, site training and e-learning applications, and patient home dashboards for tracking clinical study progress and data. Mytrus also holds an exclusive patent for conducting virtual clinical trials in the US. Mytrus investors include BioClinica and inVentiv Health.

Learn more about Mytrus at http://www.mytrus.com or find the company on Facebook and Twitter @mytrus.


Contact

Michael Tucker
Mytrus, Inc.
(512) 535-5000
mtucker@mytrus.com